Company / R&D per Share
CervoMed Inc. R&D per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.51
FY2025
5-year range
$1.49 / $2.58
FY2023-FY2025
Trend
+68.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2.58 to $2.51 over the past 2 years.
Based on SEC 10-K filings.
2.51 in FY2025.
Declined from $2.58 to $2.51 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 68.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.51 | +68.6% |
| FY2024 | $1.49 | -42.3% |
| FY2023 | $2.58 | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026